Real-time feedback of patient-reported outcomes feasible for patients and clinicians!
MRDR still operating during COVID-19 pandemic.
The Myeloma 1000 Biobank now has samples from over 400 patients!
FRAIL-M, a trial using MRDR infrastructure, has commenced recruitment.
Dr Jessie Zhao's presentation on treatment patterns in myeloma was awarded a Snowdome travel grant.
The MRDR was well represented at the Blood 2019 conference in Perth in October.
The MRDR had a busy and productive meeting at the IMW in Boston, USA.
The MRDR reached 3000 patients registered on August 22.
An MRDR paper on renal impairment in myeloma by Prof Joy Ho was recently published.